The painkiller brand Fenbid teamed up with TPLUS Tea House to open a milk tea pop-up store, launching the "Don't Endure the Night, Sweet Tea," but the cross-industry move by a pharmaceutical brand into food sparked heated debate among netizens. Some worried it could mislead consumers, while others questioned whether it was false advertising. Although the officials clarified that the drinks contain no medicinal ingredients, the controversy did not subside. Is this collaboration a warm-hearted marketing move or a brand overstepping its bounds? And where exactly lies the boundary for cross-industry partnerships? [more…]